1Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis, 2005, 41: 1242- 1250. 被引量：1
2Schueller G, Matzek W, Kalhs P, et al. Pulmonary infections in the late period after allogeneic bone marrow transplantation: chest radiography versus computed tomography. Eur J Radiol, 2005, 53 : 489-494. 被引量：1
4McLintock LA, Jones BL. Advances in the molecular and serological diagnosis of invasive fungal infection in haematooncology patients. Br J Haematol, 2004, 126 : 289-297. 被引量：1
3Ruhnke M, Bohme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol, 2003,82 Suppl 2:S141-148. 被引量：1
4Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis,2002,34:7-14. 被引量：1
5Wingard JR. Empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis,2004,39 Suppl 1: S38-43. 被引量：1
6Rapp RP. Changing strategies for the management of invasive fungal infections. Pharmacotherapy,2004,24:4S-28S; quiz 29S-32S. 被引量：1
7Mahfouz TH, Anaissie EJ. Invasive fungal infections: new developments in prevention, diagnosis and management. Am Soc Hematol Educ Program book,2003,445-472. 被引量：1
8Marr KA,Carter RA,Boeckh M,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors.Blood,2002,100:4358-4366. 被引量：1
9Singh N,Paterson DL.Aspergillus infections in transplant recipients.Clin Microbiol Rev,2005,18:44-69. 被引量：1
10Mennink-Kersten MA,Donnelly JP,Verweij PE.Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.Lancet Infect Dis,2004,4:349-357. 被引量：1
8Morrell M, Fraser V J, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality [J].Antimicrob Agents Chemother,2005,49 (9) : 3640-3645. 被引量：1
9Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection disease[J].Clin Infect Dis,2005, 41 (9) :1242-1250. 被引量：1
10Noskin G, Pietrelli L, Gurwith M, et al. Related articles, links treatment of invasive fungal infections with amphotericin B colloid dispersion in bone marrow transplant recipients [ J ]. Bone Marrow Transplant, 1999,23 (77) :697-703. 被引量：1
